Companies
Guangzhou Institute of Energy Conversion
a Chinese Academy of Sciences institute advancing heterotrophic microalgae strains that convert cheap industrial glycerol — a biodiesel by-product — into microbial lipids, with demonstration-plant work in Guangdong.
- Country
- China
R&D
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsareach
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Chinese Academy of Sciences (CAS) | english.giec.cas.cn · corporate.energy |
| Research focus | Renewable energy including biomass energy, natural gas hydrate, geothermal, solar, ocean energy, energy materials, and energy systems. Biomass research includes biochemical and thermochemical conversion, biodiesel, bio-ethanol, and waste treatment. | english.giec.cas.cn |
| Grant | Awarded Guangdong Science and Technology Progress First Prize (2 items) and National Energy Administration National Energy Science and Technology Progress Second Prize (1 item). Has undertaken dozens of national, CAS, and local major projects. medium confidence | giec.cas.cn |
| Publications | Over 280 research papers published in professional journals in the last five years, over 100 patents authorized, and 18 books participated in editing (as of 2024). Biomass Energy Research Center has produced over 300 research papers and 30 patents. | english.giec.cas.cn · giec.cas.cn |
| Principal staff | Researchers including Yuan Zhenhong, Wang Zhongming, Lü Pengmei, Zhuang Xinshu, Sun Yongming, Kong Xiaoying, Qi Wei, Zhu Shunni, Li Ying, Ma Longlong, and Wang Tiejun. | english.giec.cas.cn · giec.cas.cn |
| Headcount | Approximately 460 registered employees as of December 2022. | english.giec.cas.cn · corporate.energy |
Independent sources: corporate.energy · english.giec.cas.cn · giec.cas.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic palm fat | specialty-fine-chem | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.